Clinical Trial Update: Radiation Boost for Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating a radiation boost for newly diagnosed glioblastoma multiforme has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Snippet

Sponsor: Methodist Healthcare | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: TERMINATED